13 January 2021

At the meeting of 8 December 2020 the RMA:

Determined Statements of Principles (SOPs) for:

Condition SOPs
allergic contact dermatitis 1/2021 2/2021
irritant contact dermatitis 3/2021 4/2021
angle-closure glaucoma 5/2021 6/2021
chronic venous insufficiency of the lower limb and varicose veins of the lower limb 7/2021 8/2021
dementia pugilistica 9/2021 10/2021
giant cell arteritis 11/2021 12/2021
psoriasis 13/2021 14/2021
psoriatic arthritis 15/2021 16/2021
acute infectious mononucleosis 17/2021 18/2021
anosmia 19/2021 20/2021
aortic aneurysm and aortic wall disorders 21/2021 22/2021
hereditary haemochromatosis 23/2021 24/2021
otitis externa 25/2021 26/2021

Notes:

  • The investigations concerning 'chronic venous insufficiency of the lower limb' and 'varicose veins of the lower limb' have resulted in the determination of Statements of Principles concerning chronic venous insufficiency of the lower limb and varicose veins of the lower limb.
  • The investigation concerning 'psoriatic arthropathy' has resulted in the determination of Statements of Principles concerning psoriatic arthritis.
  • The investigation concerning 'aortic aneurysm' has resulted in the determination of Statements of Principles concerning aortic aneurysm and aortic wall disorders.
  • The investigation concerning 'haemochromatosis' has resulted in the determination of Statements of Principles concerning hereditary haemochromatosis.

Determined New Statements of Principles (SOPs) for:

Condition SOPs
hyperacusis 27/2021 28/2021

Determined Amendment Statements of Principles (SOPs) for:

Condition SOPs
rotator cuff syndrome 29/2021 30/2021

The above SOPs take effect from 25 January 2021.

Summary of Changes

Decided to Undertake Consultation regarding:

Condition Reasons for Decision Date for Final Decision
open-angle glaucoma Intention to remove one or more factors April 2021
endometriosis Intention to remove one or more factors April 2021

The above investigation notices appear in the Government Notices Gazette of 5 January 2021.